FRANKFURT, June 28 (Reuters) - U.S. drugmaker Eli Lilly plans to shut three European facilities, resulting in the loss of most of the 900 jobs at the sites, it said in a statement on Wednesday. Lilly said that it planned to close research and development sites at Hamburg in Germany and Mont-Saint-Guibert in Belgium, as well as a manufacturing site in Basingstoke in the UK.
